Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
about
The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatasesBeta-adrenergic receptor 1 selective antagonism inhibits norepinephrine-mediated TNF-alpha downregulation in experimental liver cirrhosisRole of the sympathetic nervous system in carbon tetrachloride-induced hepatotoxicity and systemic inflammationβ-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.Selective α1B- and α1D-adrenoceptor antagonists suppress noradrenaline-induced activation, proliferation and ECM secretion of rat hepatic stellate cells in vitro.Protective effects of hypothalamic beta-endorphin neurons against alcohol-induced liver injuries and liver cancers in rat animal modelsHepatic fibrogenesis requires sympathetic neurotransmitters.Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.Association of interleukin-6 polymorphisms with susceptibility to hepatocellular carcinoma.M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice.Sympathetic Nervous System Control of Carbon Tetrachloride-Induced Oxidative Stress in Liver through α-Adrenergic Signaling.Systemic effects of white adipose tissue dysregulation and obesity-related inflammation.The myofibroblast, a key cell in normal and pathological tissue repair.A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences.Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion.A role for thrombin in liver fibrosis.The myofibroblast, multiple origins for major roles in normal and pathological tissue repair.Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats.Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.Sympathetic denervation accelerates wound contraction but delays reepithelialization in rats.The effects of voluntary exercise and prazosin on capillary rarefaction and metabolism in streptozotocin-induced diabetic male rats.Metabolic effects of prazosin on skeletal muscle insulin resistance in glucocorticoid-treated male rats.Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells.UEG Week 2015 Poster Presentations
P2860
Q27003263-6EFC2219-6EBE-4C15-8C0D-3A1BB6F8CE58Q27323077-7CFB0F59-07E7-4124-94C1-A2EA6C539CC3Q28544866-7C71FAE6-8363-4524-8D6A-C962189910FEQ33710554-B657B1CF-488C-41A5-95CD-45C2097D8D3EQ34451955-2EF21C31-EFB9-4DEC-BF6A-527E3705226EQ34941380-1A274AD6-6B28-4157-957F-03938D3ABE27Q35596352-345B464B-83D3-4125-BD31-48A37EEE5FF7Q35613902-9F08C5C6-04D1-45E1-933C-FB6985E60BFEQ35792086-D6E7F90C-0359-4763-884C-42559A4C9D84Q36064546-29D37087-ECBD-4E17-8625-57D2D188EE8AQ36424166-E4F434A8-BE0A-4A9E-8D88-D809B5576E82Q37798716-E06DB204-AA85-4722-9E4C-1FF681C55A02Q38673061-6D4A5546-6FF3-4C3B-9AEF-A11CE2311886Q39218226-6AAD85E3-C82D-416A-B8CB-69E649669D27Q40324109-49E306E0-F4A5-4288-BFCB-ABFE4DF22C11Q41551456-27D38817-E7AD-4B7B-AEB9-173E1420D865Q41791167-04F35D60-1C3C-4679-8BF5-671032B80B12Q42143818-0C0E525D-A3DA-4913-8D1D-18ED0ACD30E9Q42176477-ABD36B8A-F01E-4BA6-9C65-A0E91801DB8BQ44214021-5D6698FC-65F7-4D21-84C0-A917812EEC58Q45895068-AA51FE03-E742-4AA7-BFB9-00CDCC8E6C39Q46714733-F002FC48-8874-47D7-9DBF-172EA31F7DDAQ48173032-67643B8F-29A4-4FA5-87D9-845DA7EF1748Q48232647-60FDF9C6-BD3A-4D08-B92D-D991A82F067FQ54596371-DAF98F85-DCE1-4105-90E0-36BA19B8D326Q56934656-45ED3D91-0DA3-4270-9D92-EB40CD47D5A8
P2860
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
@en
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
@nl
type
label
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
@en
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
@nl
prefLabel
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
@en
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
@en
P2093
Alexis Desmoulière
Boris Decourt
Christiane Bedin
Laetitia Evadé
Laurence Barrier
Liliane Boussarie
Liliane Dubuisson
Michel Vidaud
P2860
P304
P356
10.1053/JHEP.2002.31166
P407
P577
2002-02-01T00:00:00Z